The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients.
Mahmoud A SeliemAhmed M MohamadinMohamed I Kotb El-SayedYahia IsmailAhmed A El-HusseinyPublished in: Breast cancer research and treatment (2024)
This study revealed that serum MIF levels may be regarded as a promising serum tumor marker for BC. Also, the rs1049829 variant of the MIF gene is considered a protective candidate against BC.